LAUSR

1111/dth.14684. 4 McMahon DE, Amerson E, Rosenbach M et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registrybased study of 414 cases. J Am Acad Dermatol 2021; 85: 46–55. https:// doi.org/10.1016/j.jaad.2021.03.092. 5 Krajewski PK, Matusiak Ł, Szepietowski JC. Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine. J Eur Acad Dermatol Venereol 2021; 35: e632–e634. 6 Quattrini L, Verardi L, Caldarola G, Peluso G, De Simone C, D’Agostino M. New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination. J Eur Acad Dermatol Venereol 2021; 35: 502. https://doi.org/10. 1111/jdv.17502. 7 Talamonti M, Galluzzo M, Chiricozzi A et al. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIOCOVID observational study. Expert Opin Biol Ther 2021; 21: 271– 277. 8 Talamonti M, Galluzzo M. Safety of COVID-19 vaccines in patients with psoriasis undergoing therapy with anti-interleukin agents. Expert Opin Biol Ther 2021; 21: 1535–1537. 9 Megna M, Potestio L, Gallo L, Caiazzo G, Ruggiero A, Fabbrocini G. Reply to "Psoriasis exacerbation after Covid-19 vaccination: report of 14 cases from a single center. J Eur Acad Dermatol Venereol 2022; 36: e11– e13. https://doi.org/10.1111/jdv.17665. 10 Damiani G, Pacifico A, Pelloni F, Iorizzo M. The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated? J Eur Acad Dermatol Venereol 2021; 35: e645–e647. https://doi.org/10.1111/jdv.17472.